Tc-99m标有PSMA-617作为前列腺癌诊断的潜在SPECT放射追踪器:复杂化优化及其体外/体外评估

Kalapaphuk Tachatumvitoon1, Charasphat Preuksarattanawut2, Thititip Tippayamontri3

  • 1Interdisciplinary Program of Biomedical Engineering, Faculty of Engineering, Chulalongkorn University, Bangkok, Thailand.

PubMed
概括

一种针对前列腺癌的新型Technetium-99m (Tc-99m) 放射性药物显示出高标签效率和稳定性. 这种标有Tc-99m标记的PSMA-617追踪剂在临床前研究中显示出前列腺癌的优秀选择性.